{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T08:27:08Z","timestamp":1793608028465,"version":"4.5.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T00:00:00Z","timestamp":1788048000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004901","name":"Foundation for Support to Research of Minas Gerais State","doi-asserted-by":"publisher","award":["APQ4035\/2017"],"award-info":[{"award-number":["APQ4035\/2017"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Foundation for Support to Research of Minas Gerais State","doi-asserted-by":"publisher","award":["APQ5079\/2023"],"award-info":[{"award-number":["APQ5079\/2023"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Foundation for Support to Research of Minas Gerais State","doi-asserted-by":"publisher","award":["RED-00067-23"],"award-info":[{"award-number":["RED-00067-23"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"CAPES","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"publisher","award":["442994\/2019-2"],"award-info":[{"award-number":["442994\/2019-2"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"publisher","award":["403278\/2023-6"],"award-info":[{"award-number":["403278\/2023-6"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.vaccine.2026.129105","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T21:44:45Z","timestamp":1789163085000},"page":"129105","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Heterologous adenovirus A2\/Leish-Tec\u00ae vaccination strategy in a murine model of visceral leishmaniasis: Potential canine vaccine with enhanced protection and potent T-cell immunity"],"prefix":"10.1016","volume":"92","author":[{"given":"Ana Carolina","family":"Amado-Gomes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna de Carvalho","family":"Cl\u00edmaco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatyane Martins","family":"Cirilo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flaviane Vieira","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabela de Brito","family":"Duval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge Lucas Nascimento","family":"Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo Eduardo","family":"Cardozo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramayanna Morais de Medeiros","family":"Brito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo Antonio Ferraz","family":"Coelho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fab\u00edola","family":"de Oliveira Paes Leme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo Santos","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Laura","family":"Grossi de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu\u00edsa Mour\u00e3o Dias","family":"Magalh\u00e3es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilian Lacerda","family":"Bueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Bruna-Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo Toshio","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2026.129105_bb0005","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s44197-024-00190-z","article-title":"Global dilemma and needs assessment toward achieving sustainable development goals in controlling Leishmaniasis","volume":"14","author":"Bamorovat","year":"2024","journal-title":"J Epidemiol Glob Health"},{"key":"10.1016\/j.vaccine.2026.129105_bb0010","doi-asserted-by":"crossref","first-page":"93","DOI":"10.9734\/ijtdh\/2025\/v46i71676","article-title":"Leishmaniasis: global epidemiology, transmission dynamics, and integrated control strategies","volume":"46","author":"Aryal","year":"2025","journal-title":"Int J Trop Dis Heal"},{"key":"10.1016\/j.vaccine.2026.129105_bb0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0122038","article-title":"Molecular detection of leishmania in phlebotomine sand flies (Diptera: Psychodidae) from a cutaneous leishmaniasis focus at xakriab\u00e1 indigenous reserve, Brazil","volume":"10","author":"R\u00eago","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2026.129105_bb0020","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1590\/1519-6984.166622","article-title":"Epidemiological aspects of human and canine visceral leishmaniasis in state of Alagoas, Northeast, Brazil","volume":"78","author":"Rocha","year":"2018","journal-title":"Braz J Biol"},{"key":"10.1016\/j.vaccine.2026.129105_bb0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0014303","article-title":"Sire risk factors for vertical transmission of leishmania infantum by the dam","volume":"20","author":"Duxbury","year":"2026","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2026.129105_bb0030","doi-asserted-by":"crossref","DOI":"10.1186\/s13071-026-07337-w","article-title":"Breed-specific immune regulation under endemic exposure to Leishmania infantum and other vector-borne pathogens in a native Mediterranean canine population","volume":"19","author":"Mart\u00ednez-S\u00e1ez","year":"2026","journal-title":"Parasit Vectors"},{"key":"10.1016\/j.vaccine.2026.129105_bb0035","article-title":"New approaches to the prevention of visceral leishmaniasis: a review of recent patents of potential candidates for a chimeric protein vaccine","volume":"12","author":"Oliveira","year":"2024","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2026.129105_bb0040","series-title":"Nota t\u00e9cnica no 038\/2014\/DFIP\/SDA: suspens\u00e3o da licen\u00e7a de fabrica\u00e7\u00e3o e comercializa\u00e7\u00e3o do produto Leishmune\u00ae \u2013 vacina contra leishmaniose visceral canina","author":"BRASIL","year":"2014"},{"key":"10.1016\/j.vaccine.2026.129105_bb0045","doi-asserted-by":"crossref","DOI":"10.3390\/vetsci9080387","article-title":"Canine leishmaniasis: update on epidemiology, diagnosis, treatment, and prevention","volume":"9","author":"Morales-Yuste","year":"2022","journal-title":"Vet Sci"},{"key":"10.1016\/j.vaccine.2026.129105_bb0050","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/tmi.13382","article-title":"Commercially approved vaccines for canine leishmaniosis: a review of available data on their safety and efficacy","volume":"25","author":"Velez","year":"2020","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.vaccine.2026.129105_bb0055","doi-asserted-by":"crossref","DOI":"10.1111\/pim.70006","article-title":"How effective are the canine visceral leishmaniasis vaccines currently being tested in dogs? A systematic review and meta-analysis","volume":"47","author":"de P\u00e1dua","year":"2025","journal-title":"Parasite Immunol"},{"key":"10.1016\/j.vaccine.2026.129105_bb0060","article-title":"Overview of commercial vaccines against canine visceral leishmaniasis: current landscape and future directions","volume":"14","author":"Martiniano de P\u00e1dua","year":"2025","journal-title":"Pathogens (Basel)"},{"key":"10.1016\/j.vaccine.2026.129105_bb0065","series-title":"MAPA suspende fabrica\u00e7\u00e3o e venda e determina o recolhimento de lotes de vacina contra leishmaniose ap\u00f3s fiscaliza\u00e7\u00e3o","author":"BRASIL","year":"2023"},{"key":"10.1016\/j.vaccine.2026.129105_bb0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002853","article-title":"Clinical and parasitological protection in a Leishmania infantum-macaque model vaccinated with adenovirus and the recombinant A2 antigen","volume":"8","author":"Grimaldi","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2026.129105_bb0075","doi-asserted-by":"crossref","first-page":"4585","DOI":"10.1016\/j.vaccine.2008.05.091","article-title":"Epitope mapping and protective immunity elicited by adenovirus expressing the leishmania amastigote specific A2 antigen: correlation with IFN-\u03b3 and cytolytic activity by CD8+ T cells","volume":"26","author":"Resende","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.129105_bb0080","doi-asserted-by":"crossref","first-page":"8807","DOI":"10.1073\/pnas.94.16.8807","article-title":"Loss of virulence in Leishmania donovani deficient in an amastigote-specific protein, A2","volume":"94","author":"Zhang","year":"1997","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.vaccine.2026.129105_bb0085","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0264-410X(01)00322-X","article-title":"Immunization with A2 protein results in a mixed Th1\/Th2 and a humoral response which protects mice against Leishmania donovani infections","volume":"20","author":"Ghosh","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.129105_bb0090","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.3390\/v16071094","article-title":"Clinical application of adenovirus (AdV): a comprehensive review","volume":"16","author":"Salauddin","year":"2024","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2026.129105_bb0095","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.gendis.2017.04.001","article-title":"Adenovirus-mediated gene delivery: potential applications for gene and cell-based therapies in the new era of personalized medicine","volume":"4","author":"Lee","year":"2017","journal-title":"Genes Dis"},{"key":"10.1016\/j.vaccine.2026.129105_bb0100","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41392-021-00487-6","article-title":"Viral vector platforms within the gene therapy landscape","volume":"6","author":"Bulcha","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.vaccine.2026.129105_bb0105","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.mib.2012.05.002","article-title":"Making an anti-amastigote vaccine for visceral leishmaniasis: rational, update and perspectives","volume":"15","author":"Fernandes","year":"2012","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.vaccine.2026.129105_bb0110","doi-asserted-by":"crossref","first-page":"11491","DOI":"10.1073\/pnas.191380898","article-title":"Complete, long-lasting protection against malaria of mice primed and boosted with two distinct viral vectors expressing the same plasmodial antigen","volume":"98","author":"Bru\u00f1a-Romero","year":"2001","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.vaccine.2026.129105_bb0115","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1089\/hum.2006.17.415","article-title":"Vaccination with replication-deficient recombinant adenoviruses encoding the main surface antigens of toxoplasma gondii induces immune response and protection against infection in mice","volume":"17","author":"Caetano","year":"2006","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.vaccine.2026.129105_bb0120","doi-asserted-by":"crossref","first-page":"3988","DOI":"10.1128\/IAI.71.7.3988-3994.2003","article-title":"Immune responses induced by the Leishmania (Leishmania) donovani A2 antigen, but not by the LACK antigen, are protective against experimental Leishmania (Leishmania) amazonensis infection","volume":"71","author":"Coelho","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2026.129105_bb0125","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41541-021-00356-x","article-title":"Adenoviral vector vaccine platforms in the SARS-CoV-2 pandemic","volume":"6","author":"Mendon\u00e7a","year":"2021","journal-title":"Npj Vaccines"},{"key":"10.1016\/j.vaccine.2026.129105_bb0130","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24032700","article-title":"A comprehensive review of mRNA vaccines","volume":"24","author":"Gote","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.vaccine.2026.129105_bb0135","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.n2195","article-title":"Vaccine induced immune thrombocytopenia and thrombosis: summary of NICE guidance","author":"Pavord","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2026.129105_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2025.114329","article-title":"Novel adenovirus vaccine vectors lacking thrombosis-associated interactions with platelet factor 4","volume":"29","author":"Sallard","year":"2026","journal-title":"IScience"},{"key":"10.1016\/j.vaccine.2026.129105_bb0145","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1128\/JVI.74.1.505-512.2000","article-title":"Canine adenovirus vectors: an alternative for adenovirus-mediated gene transfer","volume":"74","author":"Kremer","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2026.129105_bb0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0341642","article-title":"Practical guidelines for producing non-replicating canine adenovirus vectors","volume":"21","author":"Omara","year":"2026","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2026.129105_bb0155","doi-asserted-by":"crossref","DOI":"10.3791\/50833","article-title":"Production and purification of non replicative canine adenovirus type 2 derived vectors","author":"Szelechowski","year":"2013","journal-title":"J Vis Exp"},{"key":"10.1016\/j.vaccine.2026.129105_bb0160","doi-asserted-by":"crossref","DOI":"10.1590\/1678-4685-gmb-2022-0079","article-title":"The use of adenoviral vectors in gene therapy and vaccine approaches","volume":"45","author":"Ara\u00fajo","year":"2022","journal-title":"Genet Mol Biol"},{"key":"10.1016\/j.vaccine.2026.129105_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2020.155297","article-title":"A historical review of the role of cytokines involved in leishmaniasis","volume":"145","author":"Mirzaei","year":"2021","journal-title":"Cytokine"},{"key":"10.1016\/j.vaccine.2026.129105_bb0170","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.vetpar.2019.05.006","article-title":"Canine visceral leishmaniasis biomarkers and their employment in vaccines","volume":"271","author":"Giunchetti","year":"2019","journal-title":"Vet Parasitol"},{"key":"10.1016\/j.vaccine.2026.129105_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2020.155321","article-title":"The importance of T cell-derived cytokines in post-kala-azar dermal leishmaniasis","volume":"147","author":"Jafarzadeh","year":"2021","journal-title":"Cytokine"},{"key":"10.1016\/j.vaccine.2026.129105_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2025.127531","article-title":"Evaluation of MHC class I-binding peptides from Leishmania spp. for vaccine development against visceral leishmaniasis","volume":"62","author":"Zaidan","year":"2025","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.129105_bb0185","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines11020395","article-title":"The use of an adjuvant system improves innate and adaptive immune response when associated with a Leishmania (Viannia) braziliensis antigen in a vaccine candidate against L. (Leishmania) infantum infection","volume":"11","author":"Mathias","year":"2023","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2026.129105_bb0190","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens11090974","article-title":"LBMPL vaccine therapy induces progressive organization of the spleen microarchitecture, improved Th1 adaptative immune response and control of parasitism in Leishmania infantum naturally infected dogs","volume":"11","author":"Roatt","year":"2022","journal-title":"Pathogens"},{"key":"10.1016\/j.vaccine.2026.129105_bb0195","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.00217","article-title":"A vaccine therapy for canine visceral leishmaniasis promoted significant improvement of clinical and immune status with reduction in parasite burden","volume":"8","author":"Roatt","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2026.129105_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2022.104592","article-title":"A specific Leishmania infantum polyepitope vaccine triggers Th1-type immune response and protects against experimental visceral leishmaniasis","volume":"380","author":"Lopes Valentim Di Paschoale Ostolin","year":"2022","journal-title":"Cell Immunol"},{"key":"10.1016\/j.vaccine.2026.129105_bb0205","doi-asserted-by":"crossref","first-page":"5494","DOI":"10.1016\/j.vaccine.2022.08.005","article-title":"Immunoprophylaxis using polypeptide chimera vaccines plus adjuvant system promote Th1 response controlling the spleen parasitism in hamster model of visceral leishmaniasis","volume":"40","author":"Gusm\u00e3o","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.129105_bb0210","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1186\/s13071-017-2576-8","article-title":"Selection strategy of phage-displayed immunogens based on an in vitro evaluation of the Th1 response of PBMCs and their potential use as a vaccine against Leishmania infantum infection","volume":"10","author":"Ramos","year":"2017","journal-title":"Parasit Vectors"},{"key":"10.1016\/j.vaccine.2026.129105_bb0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vetpar.2009.05.022","article-title":"Directions for the diagnosis, clinical staging, treatment and prevention of canine leishmaniosis","volume":"165","author":"Solano-Gallego","year":"2009","journal-title":"Vet Parasitol"},{"key":"10.1016\/j.vaccine.2026.129105_bb0220","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3390\/immuno2010015","article-title":"Host\u2013pathogen interaction in leishmaniasis: immune response and vaccination strategies","volume":"2","author":"Yasmin","year":"2022","journal-title":"Immuno"},{"key":"10.1016\/j.vaccine.2026.129105_bb0225","doi-asserted-by":"crossref","DOI":"10.1186\/s13071-016-1752-6","article-title":"Multicomponent LBSap vaccine displays immunological and parasitological profiles similar to those of Leish-Tec\u00ae and Leishmune\u00ae vaccines against visceral leishmaniasis","volume":"9","author":"de Mendon\u00e7a","year":"2016","journal-title":"Parasit Vectors"},{"key":"10.1016\/j.vaccine.2026.129105_bb0230","doi-asserted-by":"crossref","first-page":"5400","DOI":"10.1016\/j.vaccine.2023.07.020","article-title":"Development of chimeric protein as a multivalent vaccine for human Kinetoplastid infections: Chagas disease and leishmaniasis","volume":"41","author":"Cl\u00edmaco","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.129105_bb0235","first-page":"118","article-title":"Induction of sensitivity to ganciclovir in human hepatocellular carcinoma cells by adenovirus-mediated gene transfer of herpes simplex virus thymidine kinase","volume":"22","author":"Qian","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.vaccine.2026.129105_bb0240","doi-asserted-by":"crossref","first-page":"3920","DOI":"10.1128\/jvi.69.6.3920-3923.1995","article-title":"Efficient selection of recombinant adenoviruses by vectors that express beta-galactosidase","volume":"69","author":"Schaack","year":"1995","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2026.129105_bb0245","doi-asserted-by":"crossref","DOI":"10.3390\/tropicalmed8090444","article-title":"Subcutaneous, oral, and intranasal immunization of BALB\/c mice with Leishmania infantum K39 antigen induces non-protective humoral immune response","volume":"8","author":"da Silva","year":"2023","journal-title":"Trop Med Infect Dis"},{"key":"10.1016\/j.vaccine.2026.129105_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.actatropica.2024.107125","article-title":"Intranasal delivery of LaAg vaccine improves immunity of aged mice against visceral leishmaniasis","volume":"252","author":"Salgado","year":"2024","journal-title":"Acta Trop"},{"key":"10.1016\/j.vaccine.2026.129105_bb0255","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.vaccine.2013.12.046","article-title":"Comparison of two commercial vaccines against visceral leishmaniasis in dogs from endemic areas: IgG, and subclasses, parasitism, and parasite transmission by xenodiagnosis","volume":"32","author":"Fernandes","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.129105_bb0260","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1128\/AAC.01787-15","article-title":"Preclinical studies evaluating subacute toxicity and therapeutic efficacy of LQB-118 in experimental visceral leishmaniasis","volume":"60","author":"Cunha-J\u00fanior","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.vaccine.2026.129105_bb0265","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1051\/vetres:2005033","article-title":"Immunogenicity in dogs of three recombinant antigens (TSA, LeIF and LmSTI1) potential vaccine candidates for canine visceral leishmaniasis","volume":"36","author":"Fujiwara","year":"2005","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2026.129105_bb0270","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.00909","article-title":"Factors which contribute to the immunogenicity of non-replicating adenoviral vectored vaccines","volume":"11","author":"Coughlan","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2026.129105_bb0275","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/j.vaccine.2009.01.091","article-title":"Advances in saponin-based adjuvants","volume":"27","author":"Sun","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.129105_bb0280","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1016\/j.vaccine.2016.03.019","article-title":"Field randomized trial to evaluate the efficacy of the Leish-Tec \u00ae vaccine against canine visceral leishmaniasis in an endemic area of Brazil","volume":"34","author":"Regina-Silva","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.129105_bb0285","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1365-3024.2006.00817.x","article-title":"Immunohistological features of visceral leishmaniasis in BALB\/c mice","volume":"28","author":"Carri\u00f3n","year":"2006","journal-title":"Parasite Immunol"},{"key":"10.1016\/j.vaccine.2026.129105_bb0290","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.624009","article-title":"Role of cytokines in experimental and human visceral leishmaniasis","volume":"11","author":"Samant","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.vaccine.2026.129105_bb0295","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1297-9716-42-39","article-title":"Mechanisms of resistance and susceptibility to experimental visceral leishmaniosis: BALB\/c mouse versus syrian hamster model","volume":"42","author":"Nieto","year":"2011","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2026.129105_bb0300","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1261074","article-title":"Elucidating the role played by bone marrow in visceral leishmaniasis","volume":"13","author":"Veras","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.vaccine.2026.129105_bb0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111671","article-title":"Host immune response against leishmaniasis and parasite persistence strategies: a review and assessment of recent research","volume":"139","author":"Elmahallawy","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.vaccine.2026.129105_bb0310","series-title":"Macrophages - Celebr. 140 Years Discov.","article-title":"The tale of mastering macrophage environment through the control of inflammasome-mediated macrophage activation and cAMP homeostasis by the protozoan parasite leishmania","author":"Bhattacharjee","year":"2022"},{"key":"10.1016\/j.vaccine.2026.129105_bb0315","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.vetimm.2008.11.020","article-title":"Expression of IFN-\u03b3, TNF-\u03b1, IL-10 and TGF-\u03b2 in lymph nodes associates with parasite load and clinical form of disease in dogs naturally infected with Leishmania (Leishmania) chagasi","volume":"128","author":"Alves","year":"2009","journal-title":"Vet Immunol Immunopathol"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129105_bb0320","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1021\/acsinfecdis.5c00859","article-title":"IL-33\/ST2 signaling protects the heart by restraining inflammation and parasite burden during Trypanosoma cruzi experimental infection","volume":"12","author":"Cardozo","year":"2026","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.vaccine.2026.129105_bb0325","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/j.vaccine.2013.01.048","article-title":"Induction of immunogenicity by live attenuated Leishmania donovani centrin deleted parasites in dogs","volume":"31","author":"Fiuza","year":"2013","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2600914X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2600914X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T07:38:17Z","timestamp":1793605097000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X2600914X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":65,"alternative-id":["S0264410X2600914X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.129105","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heterologous adenovirus A2\/Leish-Tec\u00ae vaccination strategy in a murine model of visceral leishmaniasis: Potential canine vaccine with enhanced protection and potent T-cell immunity","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.129105","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"129105"}}